Effect of omeprazole therapy on the survival of Helicobacter pylori, urease activity, and antral gastric histology in patients with duodenal ulcer

Helicobacter

Volumn 1, Issue 3, 1996, Pages 155-158

  Nakshabendi, Imad M ^a   Zhang, Quibo B ^a   Mokhashi, Mahesh ^a   Gemmell, Curtis G ^a   Lee, Frederick D ^a   Russell, Robin I ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIULCER AGENT; BACTERIAL PROTEIN; ENZYME INHIBITOR; UREASE;

ADULT; AGED; ARTICLE; BIOPSY; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; DUODENOSCOPY; DUODENUM ULCER; ENZYMOLOGY; FEMALE; GASTRITIS; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; STOMACH ANTRUM; TREATMENT OUTCOME;

ADULT; AGED; ANTI-ULCER AGENTS; BACTERIAL PROTEINS; BIOPSY; DRUG EVALUATION; DUODENAL ULCER; DUODENOSCOPY; ENZYME INHIBITORS; FEMALE; GASTRITIS; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PYLORIC ANTRUM; TREATMENT OUTCOME; UREASE;

EID: 0030223137     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-5378.1996.tb00030.x     Document Type: Article

References (24)

1. Blaser MJ. Campylobacter-like organisms, gastritis, and peptic ulcer disease. Gastroenterology 1987;93:371-83.
2. Goodwin CS, Armstrong JA, Marshall BJ. Campylobacter pyloridis, gastritis, and peptic ulceration. J Clin Pathol 1986;39:353-65.
3. Bader JP, Walan A, eds. Proceedings of the International Symposium on Omeprazole, Monte Carlo, Monaco, November 11-12, 1988. Scand J Gastroenterol 1989;24(suppl 166).
4. Daw MA, Deegan P, Leen E, O'Morain C. Short report: The effect of omeprazole on Helicobacter pylori and associated gastritis. Aliment Pharmacol Ther 1991;5(4):435-9.
5. Iwahi T, Satoh H, Nako M, Iwasaki T, Yamazaki T, Kubo K, Tamura T, Imada A. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicrob Agents Chemother 1991;35(3):490-6.
6. Hui WM, Lam SK, Ho J, Lai CL, Lok AS, Ng MM, Lau WY, Branicki FJ. Effect of omeprazole on duodenal ulcer-associated antral gastritis and Helibacter pylori. Dig Dis Sci 1991;36:577-82.
7. Bell GD, Powell KU, Burridge SM, Bowden AN, Rameh B, Bolton G, Purser K, Harrison G, Brown C, Gant PW, Jones PH, Trowell JE. Helicobacter pylori eradication: Efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens. Q J Med 1993;86:743-50.
8. Zhang QB, Nakshabendi I, Mokhashi M, Russell RI, Gemmell CG. Omeprazole can inhibit cell vacuolation in vero cells induced by culture supernatants of H. pylori [abstract]. Gut 1994;5:S35.
9. Eaton KA, Brooks CL, Morgan DR, et al. Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect Immun 1991;59:2470-5.
10. Triebling AT, Korsten MA, Dlugosz JW, Paronetto F, Lieber CS. Severity of Helicobacter pylori-induced gastric injury correlates with gastric juice ammonia. Dig Dis Sci 1991;36:1089-96.
11. Price A. The Sydney system; Histological division. J Gastroenterol Hepatol 1991;6:204-22.
12. Whitehead R, Truelove SC, Gear MWL. The histological diagnosis of chronic gastritis in fibreoptic gastroscope biopsy specimens. J Clin Pathol 1972;25:1-11.
13. Loffeld RJL, Potters HVPJ, Arends JW, Stobberingh E, Flendrig JA, Van Spreeuwel JP. Campylobacter associated gastritis in patients with non-ulcer dyspepsia. J Clin Pathol 1988;41:85-8.
14. Buck GE, Smith JS. Medium supplementation for growth of Campylobacter pyloridis. J Clin Microbiol 1987;25:597-9.
15. Dunn BE, Campbell GP, Perez-Perez GI, Blaser MJ. Purification and characterization of urease from Helicobacter pylori. J Biol Chem 1990;265:9464-9.
16. Mobley HLT, Cortesin MJ, Rosenthal LE, Jones BD. Characterization of urease from Campylobacter pylori. J Clin Microbiol 1988;26:831-6.
17. Rauws EA, Tytgat GN. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990;1:1233-5.
18. Marshall BJ, Goodwin CS, Warren JR, Murray R, Blincow ED, Blackbourn SJ, Phillips M, Waters TE, Sanderson CR. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campybacter pylori. Lancet 1988;2:1437-42.
19. Rauws EA, Langenberg W, Houthoff HJ, Zanen HC, Tytgat GN. Campylobacter pyloridis-associated chronic active antral gastritis: A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 1988;94:33-40.
20. Weill J, Bell GD, Powell K, Morden A, Harrison G, Gant PW, Jones PH, Trowell JE. Omeprazole and Helicobacter pylori: Temporary suppression rather than true eradication. Aliment Pharmacol Ther 1991;5:309-13.
21. Logan RPH, Bardhan KD, Celestin LR, Theodossi A, Palmer KR, Reed PI, Baron JH, Misiewicz JJ (for the BHURG study). Eradication of Helicobacter pylori and prevention of recurrence of duodenal ulcer: A randomized, double-blind, multicentre trial of omeprazole with or without clarithromycin. Aliment Pharmacol Ther 1995; 9:417-23.
22. Bayerdorffer E, Mannes GA, Sommer A, Hochter W, Weingarts J, Hart R, et al. High-dose omeprazole treatment combined with amoxycilline eradicates Helicobacter pylori. Eur J Gastroenterol Hepatol 1992;4:697-702.
23. Allan Gray JD, Shiner M. Influence of gastric pH on gastric and jejunal flora. Gut 1967;8:574-81.
24. Neal KR. Omeprazole and risks of campylobacter gastroenteritis. Federation of Infection Societies Conference Reporty Manchester, England, May 4-5 1994;6.